Jones Financial Companies’s Allarity Therapeutics ALLR Stock Holding History

Jones Financial Companies’s Portfolio ALLR Stock Details ALLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	4957
2026 Q1	$1	Buy	+1	New	+$1	﹤0.01%	4720

Other funds holding ALLR

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jones Financial Companies's ALLR Position: Q2 2026 in Review

Jones Financial Companies held its Allarity Therapeutics (ALLR) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4957.

Jones Financial Companies first reported a position in ALLR in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

Jones Financial Companies held 1 share of Allarity Therapeutics worth $1 as of Q2 2026.
Jones Financial Companies left its Allarity Therapeutics share count unchanged in Q2 2026.
Allarity Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4957 holding.
Jones Financial Companies first reported a position in Allarity Therapeutics in Q1 2026 and has held it in 2 quarters since.
19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.